http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2875734-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_442519b1c08867cccfb1e54fa4fc6654 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate | 2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bccef1567170998f8971eb6be5525c7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4170d263edeb73bd1d02a9f24a8944 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a546a68b45d8f1c1a6b4d2d807203419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df1753747205b811580e0be34770104 |
| publicationDate | 2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2875734-T3 |
| titleOfInvention | Derivatives of 9H-pyrrolo-dipyridine |
| abstract | A compound of general formula I, or a pharmaceutically acceptable acid addition salt, a racemic mixture or its corresponding enantiomer and/or optical isomers thereof, **(See formula)** where R1 is pyrazole, thiazole, pyridine or pyrimidine, optionally substituted with one or two substituents selected from fluorine; methyl or ethyl or propyl, optionally substituted with fluorine or methoxy; cyan; amino optionally substituted with methyl or fluoro-ethyl; C(O)N-methyl, or -ethyl or -propyl, optionally substituted with fluorine or methoxy; methoxy or ethoxy or propoxy, optionally substituted with fluorine or methoxy; morpholine or piperazine or piperidine, optionally substituted with fluorine or fluoromethyl; X is N, Y is CH, and Z is CH; or X is CH, Y is N and Z is CH; and A is CH, D is N, M is C-R3, and Q is CH; or A is CH, D is N, M is CH, and Q is C-R3; or A is CH, D is C-R3, M is N, and Q is CH; or A is CH, D is CH, M is C-R3 and Q is N; and R3 is H; fluorine; methyl or ethyl or propyl optionally substituted with fluorine, hydroxy or methoxy; methoxy or ethoxy or propoxy optionally substituted with fluorine or hydroxyl or methoxy; di-methyl-amino; NH-methyl or ethyl or propyl optionally substituted with fluorine, hydroxy or methoxy; and wherein any H in the formula is H or its 2H or 3H isotope; any C in the general formula is C or its radioactive isotope 14C or 11C; any F of the formula is F or its radioactive isotope 18F provided that the compound of formula I is not a compound of the general formula Ro I **(See formula)** where R is hydrogen or tritium; F is fluorine or 18fluoro; or a pharmaceutically acceptable acid addition salt thereof |
| priorityDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 376.